Arkolith/Insider Trading/VTYX/Form 4

Nuss John

CHIEF SCIENTIFIC OFFICERVentyx Biosciences, Inc. (VTYX) · full profile →Form 4 · filed Dec 19, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$30K
Net Open-Market Flow
-$30K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 19, 2024Sell(S)13K$2.26$30K486K
Dec 17, 2024Option exercise(M)35K—$0499K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 17, 2024Option exercise(M)35K—$035K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-029920) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML